NCT00439738View on ClinicalTrials.gov

Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

412

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

November 30, 2007

Conditions
Hypertension
Interventions
DRUG

HCTZ + Amlodipine

"* 12.5 mg HCTZ capsules~* 25 mg HCTZ capsules~* 5 mg amlodipine capsules~* 10 mg amlodipine capsules"

DRUG

Valsartan/HCTZ

"* 160 mg film-coated valsartan tablets~* 320 mg film-coated valsartan tablets~* 12.5 mg HCTZ capsules~* 25 mg HCTZ capsules"

Trial Locations (5)

35662

Terence T. Hart, MD, Muscle Shoals

73132

Oklahoma Cardiovascular & Hypertension, Oklahoma City

76040

Northeast Tarrant Internal Medicine Assoc, Euless

91361

Westlake Medical Research, Westlake Village

98366

Frandsen Family Medicine, Port Orchard

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY